SCCA2 is a reliable biomarker for evaluating pediatric atopic dermatitis - 04/05/18
Doi : 10.1016/j.jaci.2018.01.021
Mizuho Nagao, MD, PhD a, ∗, Shinichiro Inagaki, MD, PhD b, ∗, Toshiki Kawano, MD, PhD c, Yoshinori Azuma, MS d, Noriko Nomura, MS d, Yasuhiko Noguchi, BS d, Shoichiro Ohta, MD, PhD e, Atsushi Kawaguchi, PhD f, Hiroshi Odajima, MD, PhD c, Yukihiro Ohya, MD, PhD b, Takao Fujisawa, MD, PhD a 
, Kenji Izuhara, MD, PhD e
, Kenji Izuhara, MD, PhD e a Institute for Clinical Research, Mie National Hospital, Mie, Japan
b Division of Allergy, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan
c Department of Pediatrics, Fukuoka National Hospital, Fukuoka, Japan
d Shino-Test Corporation, Sagamihara, Japan
e Division of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, Saga, Japan
f Center for Comprehensive Community Medicine, Saga Medical School, Saga, Japan
| This work was supported in part by Grants-in-Aid for Scientific Research from the Saga Medical School (to K.I.). Y.A., N.N., and Y.N. are employees of Shino-Test Corporation. |
|
| Disclosure of potential conflict of interest: K. Izuhara received research funding from Shino-test Co Ltd for this work and research funding from AstraZeneca for other works and has a patent effective only in Japan. Y. Azuma, N. Nomura, and Y. Noguchi are employed by Shino-test Co Ltd. Y. Ohya received a grant from Shino-Test Corporation for this work and grants from Japan Agency for Medical Research and Development; National Center for Child Health and Development; Ministry of Health, Labor, and Welfare, Environmental Restoration and Conservation Agency; and National Institute for Environmental Studies for other works, as well as personal fees from National Center for Child Health and Development, Shideido, Maruho, MDD (Merck Sharp and Dohme), Kyorin Pharmaceutical, Taiho Pharma, GlaxoSmithKline, Sysmex, Kyowa Hakko Kirin, Mitsubishi Tanabe Pharma, and Boehringer Ingelheim. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 141 - N° 5
P. 1934 - mai 2018 Retour au numéro
Article précédent
- Lifetime air pollution exposure and asthma in a pediatric birth cohort
- Mary B. Rice, Sheryl L. Rifas-Shiman, Augusto A. Litonjua, Matthew W. Gillman, Nicole Liebman, Itai Kloog, Heike Luttmann-Gibson, Brent A. Coull, Joel Schwartz, Petros Koutrakis, Emily Oken, Murray A. Mittleman, Diane R. Gold
- Reprograming immunity to food allergens
- Ashley L. St John, W. X. Gladys Ang, Abhay P.S. Rathore, Soman N. Abraham
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?